Haemolytic anaemia in the newborn infant.
D000017:ABO Blood-Group System; D000649:Amniocentesis; D000906:Antibodies / Q000032:analysis; D001787:Blood Group Incompatibility; D001805:Blood Transfusion, Intrauterine; D004487:Edema / Q000209:etiology; D004899:Erythroblastosis, Fetal / Q000209:etiology / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood / Q000379:methods; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology; D007019:Hypoproteinemia / Q000209:etiology; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000628:therapy; D008027:Light; D010634:Phenobarbital / Q000627:therapeutic use; D010956:Plasmapheresis; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D000906:Antibodies; D012204:Rh-Hr Blood-Group System; D010634:Phenobarbital